Thermal ablative therapy for malignant liver tumors: A critical appraisal

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 6, 2003, Pages 616-629

  Ng, Kelvin Kwok Chai ^a   Lam, Chi Ming ^a   Poon, Ronnie Tung Ping ^a   Ai, Victor ^a   Tso, Wai Kuen ^a   Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cryotherapy; Interstitial laser therapy; Malignant liver tumor; Microwave coagulation therapy; Radiofrequency ablation; Thermal ablative therapy

Indexed keywords

ALCOHOL;

ARTIFICIAL EMBOLISM; BLEEDING; CANCER MORTALITY; CANCER SURVIVAL; CATHETER ABLATION; CRYOTHERAPY; HUMAN; HYPERTHERMIC THERAPY; LAPAROTOMY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER RESECTION; LOW LEVEL LASER THERAPY; MICROWAVE RADIATION; OPEN STUDY; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; TECHNIQUE; TREATMENT INDICATION; TUMOR VOLUME;

EID: 0037713343     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.02991.x     Document Type: Review

References (152)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin. Liver Dis. 1999; 19: 271-85.
2. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference. Hepatocellular carcinoma. Ann. Intern. Med. 1988; 108: 390-401.
3. Fan ST, Lo CM, Liu CL et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann. Surg. 1999; 229: 322-30.
4. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann. Surg. 1999; 229: 790-9.
5. Poon RT, Fan ST, Lo CM et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann. Surg. 2001; 234: 63-70.
6. Yamamoto J, Kosuge T, Takayama T et al. Recurrence of hepatocellular carcinoma after surgery. Br. J. Surg. 1996; 83: 1219-22.
7. Nagasue N, Uchida M, Makino Y et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-94.
8. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N. Engl. J. Med. 1995; 332: 1256-61.
9. Pelletier G, Roche A, Ink O et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J. Hepatol. 1990; 11: 181-4.
10. Pelletier G, Ducreux M, Gay F et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J. Hepatol. 1998; 29: 129-34.
11. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-71.
12. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J. Surg. Oncol. 2000; 73: 109-14.
13. Vilana R, Bruix J, Bru C, Ayuso C, Sole M, Rodes J. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992; 16: 353-7.
14. Hasegawa S, Yamasaki N, Hiwaki T et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999; 86: 1682-90.
15. Weiss L, Grundmann E, Torhorst J et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J. Pathol. 1986; 150: 195-203.
16. Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancers. Arch. Surg. 1976; 111: 330-4.
17. Wagner JS, Adson MA, van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann. Surg. 1984; 199: 502-8.
18. Tandan VR, Harmantas A, Gallinger S. Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: a critical review of the literature. Can. J. Surg. 1997; 40: 175-81.
19. Adson MA, van Heerden JA, Adson MH, Wagner JS, Ilstrup DM. Resection of hepatic metastases from colorectal cancer. Arch. Surg. 1984; 119: 647-51.
20. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann. Surg. 1989; 210: 127-38.
21. Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J. Clin. Oncol. 1997; 15: 938-46.
22. Fong Y, Blumgart LH, Cohen A, Fortner J, Brennan MF. Repeat hepatic resections for metastatic colorectal cancer. Ann. Surg. 1994; 220: 657-62.
23. Fernandez-Trigo V, Shamsa F, Sugarbaker PH. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery 1995; 117: 296-304.
24. Wagman LD, Kemeny MM, Leong L et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J. Clin. Oncol. 1990; 8: 1885-93.
25. Martin JK Jr, O'Connell MJ, Wieand HS et al. Intraarterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch. Surg. 1990; 125: 1022-7.
26. Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature. Cancer 1996; 78: 1639-45.
27. Cooper IS. Cryogenic surgery: a new method of destruction or extirpation of benign or malignant tissue. N. Engl. J. Med. 1963; 268: 743-9.
28. Bischof JC, Rubinsky B. Large ice crystals in the nucleus of rapidly frozen liver cells. Cryobiology 1993; 30: 597-603.
29. Whittaker DK. Mechanisms of tissue destruction following cryosurgery. Ann. R. Coll. Surg. Engl. 1984; 66: 313-18.
30. Brown NJ, Bayjoo P, Reed MW. Effect of cryosurgery on liver blood flow. Br. J. Cancer 1993; 68: 10-12.
31. Rubinsky B, Lee CY, Bastacky J, Onik G. The process of freezing and the mechanism of damage during hepatic cryosurgery. Cryobiology 1990; 27: 85-97.
32. Cuschieri A, Crosthwaite G, Shimi S et al. Hepatic cryotherapy for liver tumors. Development and clinical evaluation of a high-efficiency insulated multineedle probe system for open and laparoscopic use. Surg. Endosc. 1995; 9: 483-9.
33. Silverman SG, Tuncali K, Adams DF et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 2000; 217: 657-64.
34. Huang A, McCall JM, Weston MD et al. Phase I study of percutaneous cryotherapy for colorectal liver metastasis. Br. J. Surg. 2002; 89: 303-10.
35. Lam CM, Shimi SM. Needle implantation cryoprobes. Biophysical and thermal characteristics. Semin. Laparosc. Surg. 1997; 4: 89-95.
36. Neel HB 3rd, Ketcham AS, Hammond WG. Cryonecrosis of normal and tumor-bearing rat liver potentiated by inflow occlusion. Cancer 1971; 28: 1211-18.
37. Zacarian SA. The observation of freeze-thaw cycles upon cancer-cell suspensions. J. Dermatol. Surg. Oncol. 1977; 3: 173-4.
38. Dilley AV, Warlters A, Dy D. Hepatic cryotherapy: is portal clamping worth it? (Abstract.) Aust. NZ J. Surg. 1991; 61: A522.
39. Wong WS, Patel SC, Cruz FS, Gala KV, Turner AF. Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation. Cancer 1998; 82: 1268-78.
40. Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann. Surg. 1997; 225: 39-8.
41. Crews KA, Kuhn JA, McCarty TM, Fisher TL, Goldstein RM, Preskitt JT. Cryosurgical ablation of hepatic tumors. Am. J. Surg. 1997; 174: 614-17.
42. Pearson AS, Izzo F, Fleming RY et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am. J. Surg. 1999; 178: 592-9.
43. Cha C, Lee FT Jr, Rikkers LF, Niederhuber JE, Nguyen BT, Mahvi DM. Rationale for the combination of cryoablation with surgical resection of hepatic tumors. J. Gastrointest. Surg. 2001; 5: 206-13.
44. Ravikumar TS, Kane R, Cady B, Jenkins R, Clouse M, Steele G Jr. A 5-year study of cryosurgery in the treatment of liver tumors. Arch. Surg. 1991; 126: 1520-3.
45. Ruers TJ, Joosten J, Jager GJ, Wobbes T. Long-term results of treating hepatic colorectal metastases with cryosurgery. Br. J. Surg. 2001; 88: 844-9.
46. Zhou XD, Tang ZY, Yu YQ. Cryosurgery for liver tumors. In: Kawasaki Se, Makuuchi M, eds. Novel Regional Therapies for Liver Tumors. New York: RG Landes Company, 1995; 187-96.
47. Preketes AP, Caplehorn JR, King J, Clingan PR, Ross WB, Morris DL. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J. Surg. 1995; 19: 768-71.
48. Shafir M, Shapiro R, Sung M, Warner R, Sicular A, Klipfel A. Cryoablation of unresectable malignant liver tumors. Am. J. Surg. 1996; 171: 27-31.
49. Buscarini L, Buscarini E, Di Stasi M, Quaretti P, Zangrandi A. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med. 1999; 20: 47-53.
50. Weaver ML, Ashton JG, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin. Surg. Oncol. 1998; 14: 163-70.
51. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann. Surg. 1998; 228: 201-8.
52. Zhou XD, Tang ZY, Yu YQ et al. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases. J. Cancer Res. Clin. Oncol. 1993; 120: 100-2.
53. Lam CM, Yuen WK, Fan ST. Hepatic cryosurgery for recurrent hepatocellular carcinoma after hepatectomy: a preliminary report. J. Surg. Oncol. 1998; 68: 104-6.
54. Morris DL, Ross WB, Iqbal J, McCall JL, King J, Clingan PR. Cryoablation of hepatic malignancy: an evaluation of tumour marker data and survival in 110 patients. GI Cancer 1996; 1: 247-51.
55. Ravikumar TS, Steele G Jr, Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res. 1991; 51: 6323-7.
56. Kane RA. Ultrasound-guided hepatic cryosurgery for tumour ablation. Semin. Interven. Radiol. 1993; 10: 132-42.
57. Chung MH, Ye W, Ramming KP, Bilchik AJ. Repeat hepatic cryotherapy for metastatic colorectal cancer. J. Gastrointest. Surg. 2001; 5: 287-93.
58. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J. Surg. 1999; 23: 109-13.
59. Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int. J. Hyperthermia 1994; 10: 457-83.
60. Christophi C, Winkworth A, Muralihdaran V, Evans P. The treatment of malignancy by hyperthermia. Surg. Oncol. 1998; 7: 83-90.
61. Bertone V, Barni S, Silvotti MG, Freitas I, Mathe G, Pontiggia P. Hyperthermic effects on the human metastatic liver: aTEM study. Anticancer Res. 1997; 17: 4713-16.
62. Honda N, Guo Q, Uchida H, Ohishi H, Hiasa Y. Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy. Radiology 1994; 190: 53-7.
63. Yoon HK, Song HY, Sung KB et al. Percutaneous hot saline injection: effectiveness in large hepatocellular carcinoma. Vasc. Interv. Radiol. 1999; 10: 477-82.
64. Izzo F, Fiore F, Werra C. Alternative treatment approaches to early stage or unresectable hepatocellular carcinoma confined to the liver. In: Curley SA, ed. Liver Cancer. New York: Springer Verlag, 1998; 79-94.
65. Ohno T, Kawano K, Sasaki A, Aramaki M, Yoshida T, Kitano S. Expansion of an ablated site and induction of apoptosis after microwave coagulation therapy in rat liver. J. Hepatobiliary Pancreat. Surg. 2001; 8: 360-6.
66. Matthewson K, Coleridge-Smith P, O'Sullivan JP, Northfield TC, Bown SG. Biological effects of intrahepatic neodymium: yttrium-aluminum-garnet laser photocoagulation in rats. Gastroenterology 1987; 93: 550-7.
67. McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest. Radiol. 1990; 25: 267-70.
68. Rossi S, Fornari F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 1990; 76: 54-7.
69. Takeuchi H, Tamura R, Baba T et al. Real-time evaluation of the effectiveness of microwave coagulation therapy for hepatocellular carcinoma using color Doppler imaging. Acta Med. Okayama 1998; 52: 255-60.
70. Gertner MR, Worthington AE, Wilson BC, Sherar MD. Ultrasound imaging of thermal therapy in in vitro liver. Ultrasound Med. Biol. 1998; 24: 1023-32.
71. Raman SS, Lu DS, Vodopich DJ, Sayre J, Lassman C. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR Am. J. Roentgenol. 2000; 175: 1253-8.
72. Dromain C, De Baere TJ, Elias D, Ducre M, Sabourin J, Vanel D. Follow-up imaging of liver tumors treated using percutaneous radiofrequency (RF) therapy with helical CT and MRI imaging. Radiology 1999; 213: 382.
73. Hinks RS, Bronskill MJ, Kucharczyk W, Bernstein M, Collick BD, Henkelman RM. MR systems for image-guided therapy. J. Magn. Reson. Imaging 1998; 8: 19-25.
74. Rose SC, Hassanein TI, Easter DW et al. Value of three-dimensional US for optimizing guidance for ablating focal liver tumors. J. Vasc. Interv. Radiol. 2001; 12: 507-15.
75. Tsuda M, Majima K, Yamada T, Saitou H, Ishibashi T, Takahashi S. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. Clin. Imaging 2001; 25: 409-15.
76. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent - early experience. Radiology 1999; 211: 643-9.
77. Cioni D, Lencioni R, Rossi S et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. AJR Am. J. Roentgenol. 2001; 177: 783-8.
78. Sato M, Watanabe Y, Kashu Y, Nakata T, Hamada Y, Kawachi K. Sequential percutaneous microwave coagulation therapy for liver tumor. Am. J. Surg. 1998; 175: 322-4.
79. Ishikawa M, Ikeyama S, Sasaki K et al. Intraoperative microwave coagulation therapy for large hepatic tumors. J. Hepatobiliary Pancreat. Surg. 2000; 7: 587-91.
80. Steger AC, Lees WR, Walmsley K, Bown SG. Interstitial laser hyperthermia: a new approach to local destruction of tumours. BMJ 1989; 299: 362-5.
81. Moller PH, Lindberg L, Henriksson PH, Persson BR, Tranberg KG. Temperature control and light penetration in a feedback interstitial laser thermotherapy system. Int. J. Hyperthermia 1996; 12: 49-63.
82. Tranbrg KG, Moller PH, Hannesson P, Stenram U. Interstitial laser treatment of malignant tumours: initial experience. Eur. J. Surg. Oncol. 1996; 22: 47-54.
83. Nolsoe CP, Torp-Pedersen S, Burcharth F et al. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study. Radiology 1993; 187: 333-7.
84. Moller PH, Hannesson PH, Ivarsson K, Olsrud J, Stenram U, Tranberg KG. Interstitial laser thermotherapy in pig liver: effect of inflow occlusion on extent of necrosis and ultrasound image. Hepatogastroenterology 1997; 44: 1302-11.
85. Sturesson C, Liu DL, Stenram U, Andersson-Engels S. Hepatic inflow occlusion increases the efficacy of interstitial laser-induced thermotherapy in rat. J. Surg. Res. 1997; 71: 67-72.
86. Germer CT, Isbert C, Albrecht D et al. Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model. Ann. Surg. 1999; 230: 55-62.
87. Falk RE, Moffat FL, Calhoun K et al. The effect of radiofrequency hyperthermia and chemotherapy upon human neoplasms when used with adjuvant metronidazole. Surg. Gynecol. Obstet, 1983; 157: 505-12.
88. Goldberg SN, Gazelle GS, Halpern EF, Rittman WJ, Mueller PR, Rosenthal DI. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad. Radiol. 1996; 3: 212-18.
89. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001; 6: 14-23.
90. Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a peffusion electrode. Acad. Radiol. 1996; 3: 636-44.
91. Lorentzen T, Christensen NE, Nolsle CP, Torp-Pedersen ST. Radiofrequency tissue ablation with a cooled needle in vitro: ultrasonography, dose-response, and lesion temperature. Acad. Radiol. 1997; 4: 292-7.
92. Goldberg SN, Solbiati L, Hahn PF et al. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998; 209: 371-9.
93. Rossi S, Garbagnati F, De Francesco I et al. Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori 1999; 85: 128-32.
94. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann. Surg. 1998; 227: 559-65.
95. Chinn SB, Lee FT Jr, Kennedy GD et al. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. AJR Am. J. Roentgenol. 2001; 176: 789-95.
96. Aschoff AJ, Merkle EM, Wong V et al. How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver? J. Magn. Reson. Imaging 2001; 13: 57-63.
97. Matsukawa T, Yamashita Y, Arakawa A et al. Percutaneous microwave coagulation therapy in liver tumors. A 3-year experience. Acta Radiol. 1997; 38: 410-15.
98. Shimada S, Hirota M, Beppu T et al. Complications and management of microwave coagulation therapy for primary and metastatic liver tumors. Surg. Today 1998; 28: 1130-7.
99. Seki T, Wakabayashi M, Nakagawa T et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74: 817-25.
100. Ohmoto K, Miyake I, Tsuduki M et al. Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 2894-900.
101. Lu MD, Chen JW, Xie XY et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001; 221: 167-72.
102. Abe T, Shinzawa H, Wakabayashi H et al. Value of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in relation to tumor size and location. Endoscopy 2000; 32: 598-603.
103. Seki S, Sakaguchi H, Kadoya H et al. Laparoscopic microwave coagulation therapy for hepatocellular carcinoma. Endoscopy 2000; 32: 591-7.
104. Yamashita Y, Sakai T, Maekawa T, Watanabe K, Iwasaki A, Shirakusa T. Thoracoscopic transdiaphragmatic microwave coagulation therapy for a liver tumor. Surg. Endosc. 1998; 12: 1254-8.
105. Hamazoe R, Hirooka Y, Ohtani S, Katoh T, Kaibara N. Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinoma. Cancer 1995; 75: 794-800.
106. Yamanaka N, Tanaka T, Oriyama T, Furukawa K, Tanaka W, Okamoto E. Microwave coagulonecrotic therapy for hepatocellular carcinoma. World J. Surg. 1996; 20: 1076-81.
107. Midorikawa T, Kumada K, Kikuchi H et al. Microwave coagulation therapy for hepatocellular carcinoma. J. Hepatobiliary Pancreat. Surg. 2000; 7: 252-9.
108. Kato T, Tamura S, Tekin A et al. Use of microwave coagulation therapy in liver transplant candidates with hepatocellular carcinoma: a preliminary report. Transplant Proc. 2001; 33: 1469.
109. Sato M, Tokui K, Watanabe Y et al. Generalized intraperitoneal seeding of hepatocellular carcinoma after microwave coagulation therapy: a case report. Hepatogastroenterology 1999; 46: 2561-4.
110. Itamoto T, Katayama K, Fukuda S et al. Percutaneous microwave coagulation therapy for primary or recurrent hepatocellular carcinoma: long-term results. Hepatogastroenterology 2001; 48: 1401-5.
111. Izumi N, Asahina Y, Noguchi O et al. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001; 91: 949-56.
112. Hashimoto D, Takami M, Ideezuki Y. In depth radiation therapy by Nd: YAG laser for malignant tumors of the liver under ultrasonic imaging. (Abstract.) Gastroenterology 1985; 88: A1663.
113. Amin Z, Donald JJ, Masters A et al. Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology 1993; 187: 339-47.
114. Schroder T, Castren-Persons M, Lehtinen A, Taavitsainen M. Percutaneous interstitial laser hyperthermia in clinical use. Ann. Chir. Gynaecol. 1994; 83: 286-90.
115. Masters A, Steger AC, Lees WR, Walmsley KM, Bown SG. Interstitial laser hyperthermia: a new approach for treating liver metastases. Br. J. Cancer 1992; 66: 518-22.
116. Gilliams AR, Brokes J, Hare C. Follow-up of patients with metastatic liver lesions treated with interstitial laser therapy. Br. J. Cancer 1997; 76: 31.
117. Vogl TJ, Muller PK, Hammerstingl R et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: technique and prospective results. Radiology 1995; 196: 257-65.
118. Vogl TJ, Mack MG, Straub R, Roggan A, Felix R. Magnetic resonance imaging - guided abdominal interventional radiology: laser-induced thermotherapy of liver metastases. Endoscopy 1997; 29: 577-83.
119. Vogl TJ, Eichler K, Straub R et al. Laser-induced thermotherapy of malignant liver tumors: general principals, equipment(s), procedure(s) - side effects, complications and results. Eur. J. Ultrasound 2001; 13: 117-27.
120. Giorgio A, Tarantino L, de Stefano G et al. Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients. Eur. J. Ultrasound 2000; 11: 181-8.
121. Christophi C, Muralidharan V. Treatment of hepatocellular carcinoma by percutaneous laser hyperthermia. J. Gastroenterol. Hepatol. 2001; 16: 548-52.
122. Rossi S, Di Stasi M, Buscarini E et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am. J. Roentgenol. 1996; 167: 759-68.
123. Rossi S, Buscarini E, Garbagnati F et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am. J. Roentgenol. 1998; 170: 1015-22.
124. Solbiati L, Goldberg SN, Ierace T et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997; 205: 367-73.
125. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-61.
126. Curley SA, Izzo F, Delrio P et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann. Surg. 1999; 230: 1-8.
127. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann. Surg. 2000; 232: 381-91.
128. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations and complications. Ann. Surg. Oncol. 2000; 7: 593-600.
129. Siperstein A, Garland A, Engle K et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann. Surg. Oncol. 2000; 7: 106-13.
130. Nicoli N, Casaril A, Marchiori L et al. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma. Chit. Ital. 2000; 52: 29-40.
131. Bowles BJ, Machi J, Limm WM et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch. Surg. 2001; 136: 864-9.
132. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur. Radiol. 2001; 11: 914-21.
133. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur. J. Ultrasound 2001; 13: 149-58.
134. Iannitti DA, Dupuy DE, Mayo-Smith WW, Murphy B. Hepatic radiofrequency ablation. Arch. Surg. 2002; 137: 422-6.
135. Solbiati L, Ierace T, Goldberg SN et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202: 195-203.
136. McGahan JP, Dodd GD III Radiofrequency ablation of the liver: current status. AJR Am. J. Roentgenol. 2001; 176: 3-16.
137. Curley SA, Izzo F. Laparoscopic radiofrequency. Ann. Surg. Oncol. 2000; 7: 78-9.
138. Dominique E, El Otmany A, Goharin A, Attalah D, de Baere T. Intraductal cooling of the main bile ducts during intraoperative radiofrequency ablation. J. Surg. Oncol. 2001; 76: 297-300.
139. Scudamore CH, Lee SI, Patterson EJ et al. Radiofrequency ablation followed by resection of malignant liver tumors. Am. J. Surg. 1999; 177: 411-17.
140. Llovet JM, Vilana R, Bru C et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-9.
141. Fujimoto T. The experimental and clinical studies of percutaneous ethanol injection therapy (PEIT) under ultrasonography for small hepatocellular carcinoma. Acta Hepatol. Jpn. 1988; 29: 52-6.
142. Livraghi T, Bolondi L, Lazzaroni S et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69: 925-9.
143. Seki T, Wakabayashi M, Nakagawa T et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999; 85: 1694-702.
144. Amin Z, Bown SG, Lees WR. Local treatment of colorectal liver metastases: a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin. Radiol. 1993; 48: 166-71.
145. Lencioni R, Cioni D, Paolicehi A. Percutaneous treatment of small hepatocellular carcinoma: radiofrequency ablation versus percutaneous ethanol injection: a prospective randomized trial (2nd report). Radiology 1998; 209: 174.
146. Livraghi T, Goldberg SN, Meloni F. Percutaneous ablation of small hepatocellular carcinoma (HCC): a prospective comparison between percutaneous ethanol injection (PEI) and radiofrequency (RF) ablation therapy. Radiology 1998; 209: 175.
147. Bilchik AJ, Wood TF, Allegra D et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch. Surg. 2000; 135: 657-62.
148. Goldberg SN, Hahn PF, Tanabe KK et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J. Vasc. Interv. Radiol. 1998; 9: 101-11.
149. Rossi S, Garbagnati F, Lencioni R et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217: 119-26.
150. Lencioni R, Armillotta N, Cioni D, Petruzzi P, Paolicchi A, Bartolozzi C. Combined segmental arterial embolization and radiofrequency thermal ablation: a new therapeutic approach for large hepatocellular carcinoma. Radiology 1998; 209: 565.
151. Seki T, Tamai T, Nakagawa T et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000; 89: 1245-51.
152. Ng KKC, Lam CM, Poon RT, Fan ST. Radiofrequency ablation as a salvage procedure for ruptured hepatocellular carcinoma. Hepatogastroenterology, in press.